A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases
Kitty J. Jager(Amsterdam University Medical Centers), Carmine Zoccali(Biogem), Mark E. Rosenberg(American University of the Caribbean School of Medicine), Vivekanand Jha(The George Institute for Global Health), Robyn G. Langham(St Vincent's Hospital Melbourne), Csaba P. Kövesdy(University of Tennessee Health Science Center)
Cited by 886
Related Papers
Worldwide access to treatment for end-stage kidney disease: a systematic review
|The Lancet|2015|2.3k
Obesity and Kidney Disease: Hidden Consequences of the Epidemic
|American Journal of Nephrology|2017|2.2k
Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study
|The Lancet|2001|1.1k
Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality
|JAMA|2014|982
Development and Validation of the American Heart Association’s PREVENT Equations
|Circulation|2023|935